TY - JOUR
T1 - Universal cardiac induction of human pluripotent stem cells in two and three-dimensional formats
T2 - implications for in vitro maturation
AU - Zhang, Miao
AU - Schulte, Jan Sebastian
AU - Heinick, Alexander
AU - Piccini, Ilaria
AU - Rao, Jyoti
AU - Quaranta, Roberto
AU - Zeuschner, Dagmar
AU - Malan, Daniela
AU - Kim, Kee-Pyo
AU - Röpke, Albrecht
AU - Sasse, Philipp
AU - Araúzo-Bravo, Marcos
AU - Seebohm, Guiscard
AU - Schöler, Hans
AU - Fabritz, Larissa
AU - Kirchhof, Paulus
AU - Müller, Frank Ulrich
AU - Greber, Boris
N1 - © 2015 AlphaMed Press.
PY - 2015/5
Y1 - 2015/5
N2 - Directed cardiac differentiation of human pluripotent stem cells (hPSCs) enables disease modeling, investigation of human cardiogenesis, as well as large-scale production of cardiomyocytes (CMs) for translational purposes. Multiple CM differentiation protocols have been developed to individually address specific requirements of these diverse applications, such as enhanced purity at a small scale or mass production at a larger scale. However, there is no universal high-efficiency procedure for generating CMs both in two-dimensional (2D) and three-dimensional (3D) culture formats, and undefined or complex media additives compromise functional analysis or cost-efficient upscaling. Using systematic combinatorial optimization, we have narrowed down the key requirements for efficient cardiac induction of hPSCs. This implied differentiation in simple serum and serum albumin-free basal media, mediated by a minimal set of signaling pathway manipulations at moderate factor concentrations. The method was applicable both to 2D and 3D culture formats as well as to independent hPSC lines. Global time-course gene expression analyses over extended time periods and in comparison with human heart tissue were used to monitor culture-induced maturation of the resulting CMs. This suggested that hPSC-CMs obtained with our procedure reach a rather stable transcriptomic state after approximately 4 weeks of culture. The underlying gene expression changes correlated well with a decline of immature characteristics as well as with a gain of structural and physiological maturation features within this time frame. These data link gene expression patterns of hPSC-CMs to functional readouts and thus define the cornerstones of culture-induced maturation.
AB - Directed cardiac differentiation of human pluripotent stem cells (hPSCs) enables disease modeling, investigation of human cardiogenesis, as well as large-scale production of cardiomyocytes (CMs) for translational purposes. Multiple CM differentiation protocols have been developed to individually address specific requirements of these diverse applications, such as enhanced purity at a small scale or mass production at a larger scale. However, there is no universal high-efficiency procedure for generating CMs both in two-dimensional (2D) and three-dimensional (3D) culture formats, and undefined or complex media additives compromise functional analysis or cost-efficient upscaling. Using systematic combinatorial optimization, we have narrowed down the key requirements for efficient cardiac induction of hPSCs. This implied differentiation in simple serum and serum albumin-free basal media, mediated by a minimal set of signaling pathway manipulations at moderate factor concentrations. The method was applicable both to 2D and 3D culture formats as well as to independent hPSC lines. Global time-course gene expression analyses over extended time periods and in comparison with human heart tissue were used to monitor culture-induced maturation of the resulting CMs. This suggested that hPSC-CMs obtained with our procedure reach a rather stable transcriptomic state after approximately 4 weeks of culture. The underlying gene expression changes correlated well with a decline of immature characteristics as well as with a gain of structural and physiological maturation features within this time frame. These data link gene expression patterns of hPSC-CMs to functional readouts and thus define the cornerstones of culture-induced maturation.
KW - cardiac differentiation
KW - human pluripotent stem cells
KW - in-vitro maturation
U2 - 10.1002/stem.1964
DO - 10.1002/stem.1964
M3 - Article
C2 - 25639979
SN - 1066-5099
VL - 33
SP - 1456
EP - 1469
JO - Stem Cells
JF - Stem Cells
IS - 5
ER -